SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,577.58 -555.23
( -0.73%)

Global Indices

Nasdaq

53,435.25 -271.85
(-0.51%)

Dow Jones

7,739.60 -29.11
(-0.37%)

Hang Seng

65,678.73 -721.11
(-1.09%)

Nikkei 225

10,817.95 -13.14
(-0.12%)

Forex

USD-INR

94.44 -0.05
(-0.05%)

EUR-INR

109.67 -0.05
(-0.04%)

GBP-INR

127.62 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524558

INE794A01010

1453.5915229

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEULANDLAB

59.07

29344.97

EPS(TTM)

Face Value()

Div & Yield %

387.19

0.15

Date	Headline
06-Aug-2026	Neuland Lab sizzles after Q1 PAT leaps over 10-fold to Rs 148 cr
06-Aug-2026	Navin Fluorine International Ltd leads gainers in 'A' group
06-Aug-2026	Volumes soar at JK Lakshmi Cement Ltd counter
06-Aug-2026	Volumes soar at Navin Fluorine International Ltd counter
05-Aug-2026	Gland and Neuland Lab announces long term strategic CDMO partnership
05-Aug-2026	Neuland Laboratories consolidated net profit rises 962.37% in the June 2026 quarter
21-Jul-2026	Neuland Laboratories to announce Quarterly Result
13-Jul-2026	Neuland Laboratories receives affirmation in credit ratings
12-May-2026	Neuland Laboratories board approves capacity additional at Unit 1
12-May-2026	Neuland Laboratories board appoints director

<< < 1 2 > >>

75,577.58 -555.23 ( -0.73%)

53,435.25 -271.85 (-0.51%)

7,739.60 -29.11 (-0.37%)

65,678.73 -721.11 (-1.09%)

10,817.95 -13.14 (-0.12%)

94.44 -0.05 (-0.05%)

109.67 -0.05 (-0.04%)

127.62 -0.01 (-0.01%)

0.60 0.00 (0.12%)